CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MRK

Letermovir 480 mg once daily

Phase 3
MERCK (MRK)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Sep '26
MRKPhase 3

Letermovir 480 mg once daily Phase 3 Est. Readout

Letermovir 480 mg once daily
Sep 2026~
CT.gov
00%
Competitive Landscape

0 competitors in Kidney Transplant; Complications

View Full Landscape
Drug Information

Target Indication

Kidney Transplant; Complications

Clinical Trial

NCT06001320

Last updated: 8/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.